MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cortical pathology in Glucocerebrosidase mutation carriers with anxiety: An MRI study

E. de Natale, H. Wilson, M. Politis (London, United Kingdom)

Meeting: MDS Virtual Congress 2020

Abstract Number: 466

Keywords: Parkinsonism

Category: Parkinson's Disease: Genetics

Objective: To employ Magnetic Resonance Imaging (MRI) and investigate structural pathology in the cortex of Glucocerebrosidase (GBA) gene mutation carriers.

Background: Mutations in the GBA gene are a risk factor for Parkinson’s disease (PD). Carriers of GBA mutations who develop PD may present with anxiety before the development of overt symptoms. The pathophysiology underlying anxiety in GBA mutation carriers is unknown.

Method: The Parkinson’s Progression Markers Initiative database was utilised to identify 86 asymptomatic GBA mutation carriers and 37 GBA mutation carriers with PD (GBA-PD). Presence of anxiety was assessed with the State Trait Anxiety Inventory (STAI), a clinical scale for anxiety divided into state (STAI-s) and trait (STAI-t) subscales. A cut-off of ≥40 was used to identify participants with anxiety. Structural MRI was used to assess volumetric changes in cortical and subcortical areas, and cortical thickness. Differences between groups were assessed with Student’s t test with correction for False Discovery Rate. Pearson’s partial correlation was used to assess relationships between structural alterations in regions associated with anxiety and clinical characteristics.

Results: Anxiety was present in 31.4% of unaffected GBA mutation carriers, and 16.2% of GBA-PD. Unaffected GBA carriers with anxiety, showed increased thickness in the lingual gyrus (2.01±0.09 vs 1.96±0.11, P=0.046) and in the paracentral gyrus (2.3±0.18 vs 2.22±0.18, P=0.04). GBA-PD with anxiety, showed decreased volumes in Substantia Nigra compared with GBA-PD without anxiety (0.53±0.05 vs 0.65±0.02, P=0.01); and thinning of the paracentral gyrus (2.1±0.14 vs 2.27±0.15, P=0.02). In the unaffected GBA population, increased thickness of the lingual gyrus correlated with the severity of anxiety (r= -0.41, P=0.035).

Conclusion: These results suggest that presence of anxiety in GBA mutation carriers is associated with pathology affecting the cortical structure. The increased thickness of areas associated with anxiety in unaffected GBA carriers may reflect early compensatory changes.

To cite this abstract in AMA style:

E. de Natale, H. Wilson, M. Politis. Cortical pathology in Glucocerebrosidase mutation carriers with anxiety: An MRI study [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/cortical-pathology-in-glucocerebrosidase-mutation-carriers-with-anxiety-an-mri-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/cortical-pathology-in-glucocerebrosidase-mutation-carriers-with-anxiety-an-mri-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley